STADA Arzneimittel

Products

Full Paper

Full Paper

Price: £95.00
Description: STADA Arzneimittel AG - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.



Research Report Overview

Published Date: 22/12/2011
Category: Therapies & Markets

Research Report Decription

STADA Arzneimittel (STADA), through its subsidiaries, develops and markets products with off-patent active pharmaceutical ingredients (APIs). It also provides over the counter (OTC), non-prescription and prescription drugs. The group operates in Europe, the Americas, Africa and Asia. It is headquartered in Bad Vilbel, Germany and employed 8,080 people as of December 31, 2010.  The group recorded revenues of E1,627 million ($2,158.5 million*) during the financial year (FY) ended December 2010, an increase of 3.7% over FY2009. The operating profit of the group was E161.8 million ($214.7 million*) during FY2010, a decrease of 15.7% over FY2009. The net profit was E68.6 million ($91 million*) in FY2010, a decrease of 31.7% over FY2009.  * Calculated using the constant conversion rate of E1 = $1.3267 for the financial year ended December 31, 2010.

Key Questions Answered:

  •  Gain understanding of  STADA Arzneimittel AG and the factors that influence its strategies
  •  Track strategic initiatives of the company and latest corporate news and actions
  •  Assess STADA Arzneimittel AG as a prospective partner, vendor or supplier
  •  Support sales activities by understanding your customers\' businesses better
  •  Stay up to date on STADA Arzneimittel AG’s business structure, strategy and prospec

Companies Mentioned:

STADA Arzneimittel

Paper Highlights:

  • Detailed information on STADA Arzneimittel AG required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting STADA Arzneimittel AG in the form of a SWOT analysis An in-depth view of the business model of STADA Arzneimittel AG including a breakdown and examination of key business segments
  • Intelligence on STADA Arzneimittel AG’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about STADA Arzneimittel AG, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends